Financhill
Sell
36

LXRX Quote, Financials, Valuation and Earnings

Last price:
$1.23
Seasonality move :
20.82%
Day range:
$1.19 - $1.24
52-week range:
$0.28 - $1.66
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.29x
P/B ratio:
3.72x
Volume:
748K
Avg. volume:
1.6M
1-year change:
56.73%
Market cap:
$447M
Revenue:
$31.1M
EPS (TTM):
-$0.19

LXRX Analysts' Consensus Rating

The 4 analysts providing 12-month price projections for Lexicon Pharmaceuticals, Inc. shares anticipate an average target of $2.88, ranging from a low estimate of $1.00 to a high estimate of $6.00. This average target implies a growth of 134.15% compared to the current stock price of $1.23.

Consensus Price Target

$2.88

Highest Price Target

$6.00

Lowest Price Target

$1.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 1 2 2

Hold 2 2 2

Sell 0 0 0
Consensus Hold Leans Bullish Leans Bullish

LXRX Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
64
GLTO alert for Dec 27

Galecto, Inc. [GLTO] is up 16.92% over the past day.

Buy
80
TVTX alert for Dec 26

Travere Therapeutics, Inc. [TVTX] is down 1.54% over the past day.

Sell
11
CDNAF alert for Dec 27

Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock